pharmaphorum

OCTOBER 26, 2022

Boehringer Ingelheim has moved one of its top pipeline prospects – oral phosphodiesterase 4B (PDE4B) inhibitor BI 1015550 – into late-stage clinical testing for idiopathic pulmonary fibrosis and other interstitial lung diseases (ILDs). First approved back in 2014, it is still growing strongly, with its 2021 sales of €2.5

Recruitment 92

Recruitment Prospecting Marketing Patients 92

Evolve Your Success

JUNE 28, 2022

In this second segment of a two-part interview, serial entrepreneur Jeff Smith shares how he found his passion and mission through pharmaceutical sales. Pharma Sales To Med Device CEO: The Jeff Smith Story Part 2. Medical sales reps are also seen as a way to be a better resource to their customers. We had $5 million in sales.

Sales 52

Sales Pharma Medical sales reps Medical sales 52

Pharmaceutical Technology

JUNE 21, 2023

This is the first time the FDA has approved an oral diabetes drug for paediatric patients since its approval of metformin in 2000. The FDA first approved Jardiance to help control blood sugar in adults with T2D in 2014. from Jardiance’s sales in 2022 while Boehringer Ingelheim made Synjardy sales amounting to €5.83bn ($6.37bn).

Medicine 59

Medicine FDA Food and Drug Administration Sales 59

Pharmaceutical Technology

JANUARY 6, 2023

The agreement outlined that Par would keep its generic equivalent off the market for as many as two years, delaying the generic launch till September 30, 2014. In a press release, the company said a generic launch would damage sales in FY 2023 by $300,000. These actions allegedly led to the extension of Novartis’ patents.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

MAY 26, 2023

The FDA has flagged this issue as pharmacies selling prescription drugs illegally have proliferated over the years. The US Food and Drug Administration (FDA commissioner Dr. Robert Califf says, “The illegal sale of prescription drug stimulants online puts Americans at risk and contributes to potential abuse, misuse, and overdose.”

Food and Drug Administration 52

Food and Drug Administration Prescription FDA Medical 52

Pharmaceutical Technology

APRIL 20, 2023

In 2022, Otezla made up for 9% of Amgen’s total product sales, having sold over $2.2 Since the lawsuit began, the FDA has approved Bristol Myers Squibb’s (BMS) Sotyktu (deucravacitinib), another small molecule for psoriasis treatment. The FDA first approved Otezla in March 2014 for the treatment of psoriatic arthritis.

Competition 52

Competition Marketing FDA Prospecting 52

Pharmaceutical Technology

NOVEMBER 30, 2022

In October, the US FDA granted Eli Lilly’s Mounjaro (tirzepatide) a Fast Track designation for its use as a treatment for obesity. Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. Anti-obesity therapeutic landscape. million in Q3.

Medical 105

Medical Manufacturing Insurance Side effects 105